Related Experiment Video
Updated: Jun 27, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Thoratec left ventricular assist device removal after toxic myocarditis
Evangelos Leontiadis1, Michiel Morshuis, Latif Arusoglu
1Department of Thoracic and Cardiovascular Medicine, Heart and Diabetes Center North-Rhine Westphalia, Ruhr-University of Bochum, Bad Oeynhausen, Germany.
Abstract:
The clinical manifestation and natural history of myocarditis range is variable from asymptomatic stages to intractable circulatory compromise and death. Supportive therapy is paramount in the treatment of this condition. The use of mechanical circulatory support as bridge-to-recovery or bridge-to-transplantation in cases of cardiovascular collapse is often the only therapeutic option for these patients. We report the case of an adolescent boy with toxic myocarditis, due to cannabis abuse, who was supported with a Thoratec left ventricular assist device (Thoratec Laboratories Corp, Pleasanton, CA) for 96 days before device removal.
Related Concept Videos
Myocarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Endocarditis III: Medical Management
Myocarditis IV: Nursing Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy

